Integrated RNAi screening identifies the NEDDylation pathway as a synergistic partner of azacytidine in acute myeloid leukemia
- Sprache
-
Englisch
- Identifier
-
1284053563
- Beteiligte Personen und Organisationen
-
Klosner, Justine
Agelopoulos, Konstantin
Rohde, Christian
Göllner, Stefanie
Schliemann, Christoph
Berdel, Wolfgang E.
Müller-Tidow, Carsten
- DOI
-
10.17879/70099652270
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
02.05.2023, 09:12 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Klosner, Justine
- Agelopoulos, Konstantin
- Rohde, Christian
- Göllner, Stefanie
- Schliemann, Christoph
- Berdel, Wolfgang E.
- Müller-Tidow, Carsten
Ähnliche Objekte (12)
Immunometabolic interplay in chronic myeloid leukemia: From immunosuppression to synergistic lethality
A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia
Transcriptional Response to Standard AML Drugs Identifies Synergistic Combinations
A novel mouse model identifies cooperating mutations and therapeutic targets critical for chronic myeloid leukemia progression
Immunogenicity of leukemia stem cells in acute myeloid leukemia
Acute Myeloid Leukemia: Aging and Epigenetics
RUNX1 mutations in acute myeloid leukemia
Current developments in acute myeloid leukemia
Identification of a novel synergistic induction of cell death by Smac-mimetic and HDAC inhibitors in acute myeloid leukemia cells
The role of ABR in myeloid differentiation and acute myeloid leukemia
Characterization of the Leukemia Initiating Cell in Human Acute Myeloid Leukemia
Treatment-free remission in chronic myeloid leukemia
Immunometabolic interplay in chronic myeloid leukemia: From immunosuppression to synergistic lethality
A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia
Transcriptional Response to Standard AML Drugs Identifies Synergistic Combinations
A novel mouse model identifies cooperating mutations and therapeutic targets critical for chronic myeloid leukemia progression
Immunogenicity of leukemia stem cells in acute myeloid leukemia
Acute Myeloid Leukemia: Aging and Epigenetics
RUNX1 mutations in acute myeloid leukemia
Current developments in acute myeloid leukemia
Identification of a novel synergistic induction of cell death by Smac-mimetic and HDAC inhibitors in acute myeloid leukemia cells
The role of ABR in myeloid differentiation and acute myeloid leukemia
Characterization of the Leukemia Initiating Cell in Human Acute Myeloid Leukemia
Treatment-free remission in chronic myeloid leukemia
Immunometabolic interplay in chronic myeloid leukemia: From immunosuppression to synergistic lethality
A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia
Transcriptional Response to Standard AML Drugs Identifies Synergistic Combinations
A novel mouse model identifies cooperating mutations and therapeutic targets critical for chronic myeloid leukemia progression
Immunogenicity of leukemia stem cells in acute myeloid leukemia
Acute Myeloid Leukemia: Aging and Epigenetics
RUNX1 mutations in acute myeloid leukemia
Current developments in acute myeloid leukemia
Identification of a novel synergistic induction of cell death by Smac-mimetic and HDAC inhibitors in acute myeloid leukemia cells
The role of ABR in myeloid differentiation and acute myeloid leukemia
Characterization of the Leukemia Initiating Cell in Human Acute Myeloid Leukemia